Home
Neuland Laboratories Ltd PE Ratio

Neuland Laboratories Ltd
NSE: NEULANDLAB
PE
Key Highlights
- The P/E Ratio of Neuland Laboratories Ltd is 70.1 as of 21 Apr 9.00 AM .
- The P/E Ratio of Neuland Laboratories Ltd changed from 22.5 on March 2020 to 27 on March 2024 . This represents a CAGR of 3.71% over 5 years.
- The Latest Trading Price of Neuland Laboratories Ltd is ₹ 13116 as of 21 Apr 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.9. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Neuland Laboratories Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Neuland Laboratories Ltd
Company Fundamentals for Neuland Laboratories Ltd

Neuland Laboratories Ltd
NSE: NEULANDLAB
Share Price
Market Price of Neuland Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Apr 2025 | 13116.2 |
17 Apr 2025 | 12824.35 |
16 Apr 2025 | 12742.1 |
15 Apr 2025 | 12655.3 |
11 Apr 2025 | 11705.4 |
09 Apr 2025 | 10943.35 |
08 Apr 2025 | 11201.8 |
07 Apr 2025 | 10949.25 |
04 Apr 2025 | 11448.9 |
03 Apr 2025 | 12037.35 |
SWOT Analysis Of Neuland Laboratories Ltd
BlinkX Score for Neuland Laboratories Ltd
Asset Value vs Market Value of Neuland Laboratories Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Neuland Laboratories Ltd | 16827 | 70.13 |
Sun Pharmaceutical Industries Ltd | 418468 | 35.5 |
Divis Laboratories Ltd | 156319 | 75.6 |
Cipla Ltd | 122071 | 24.5 |
Torrent Pharmaceuticals Ltd | 110120 | 59.1 |
Mankind Pharma Ltd | 106592 | 52.2 |
Company | |
---|---|
Neuland Laboratories Ltd | 16827 |
Sun Pharmaceutical Industries Ltd | 418468 |
Divis Laboratories Ltd | 156319 |
Cipla Ltd | 122071 |
Torrent Pharmaceuticals Ltd | 110120 |
Mankind Pharma Ltd | 106592 |
PE Ratio of Neuland Laboratories Ltd Explained
₹16827
Market cap
₹299
Earnings
70.1X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Neuland Laboratories Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Neuland Laboratories Ltd
Historical Revenue, EBITDA and Net Profit of Neuland Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Neuland Laboratories Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Neuland Laboratories Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Neuland Laboratories Ltd
About Neuland Laboratories Ltd
- Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
- The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin.
- Neuland Drugs & Pharmaceuticals Pvt.
- Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
- NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.
Neuland Laboratories Ltd News Hub
Neuland Laboratories consolidated net profit rises 58.16% in the June 2024 quarter
Net profit of Neuland Laboratories rose 58.16% to Rs 97.87 crore in the quarter ended June 2024 as a
Read more
01 Aug 24
Neuland Laboratories to declare Quarterly Result
Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 6 November 2024
Read more
18 Oct 24
Neuland Laboratories consolidated net profit declines 63.20% in the September 2024 quarter
Net profit of Neuland Laboratories declined 63.20% to Rs 32.84 crore in the quarter ended September
Read more
06 Nov 24
Neuland Laboratories Ltd leads losers in 'A' group
Hindustan Zinc Ltd, Five-Star Business Finance Ltd, Great Eastern Shipping Company Ltd and Triveni E
Read more
06 Nov 24